TROG Cancer Research
Members Login   CQMS Login  

Participant stories

Hear from past participants to hear their personal stories of taking part in a TROG Cancer Research trial. They have generously agreed to share their experience with patients considering becoming part of a trial, as well as their families and anyone else interested in learning more. 

Bob's story

Bob was diagnosed with squamous cell carcinoma (skin cancer) of the neck in 2012. He was happy to be part of the TROG POST trial. “I’m a big believer that helping someone else is a good thing,” he said.

Read more about Bob's experience

John's story

John was one of the first patients to sign-up to the TROG SPARK trial. The 70-year-old, who was diagnosed with prostate cancer, said the reduced number of hospital visits was a key attraction. “I really like the high-tech nature of this treatment; it’s fantastic to be involved in something which will hopefully lead to improvements in the field.”

Read John's story

Carol's story

Carol participated in TROG trial 07.01 (DCIS) for breast cancer patients. In this trial, doctors are looking for better ways to treat people with DCIS by testing whether an additional dose of radiation called a boost improved the chances of the cancer not returning to the breast.

 

Vic's story

Vic took part in TROG trial 08.01 (PROFIT) for prostate cancer patients. The PROFIT trial found that an eight-week course of radiation could be compressed safely into a four-week course, making the process quicker and more convenient for patients.

 

Lesley's story

Lesley signed up for the TROG trial 06.02 (APBI) for breast cancer patients. The APBI trial tested whether partial breast irradiation could be given using a new technique called 3D conformal radiation therapy.

 

Sydney's story

Like Vic, Sydney also took part in TROG trial 08.01 (PROFIT) for prostate cancer patients. The PROFIT trial helped cancer patients by condensing their treatment into just four weeks.

 

Yolanda's story

Yolanda was diagnosed with DCIS. Due to her family history, it was a diagnosis she was always expecting but never hoping for. Now, she is stronger for it. Yolanda currently participating in the TROG trial 07.01 (DCIS), which is in the follow-up stage.

This is her story 

Robert's story

Robert, who hails from New Zealand and was diagnosed with prostate cancer just prior to his 65th birthday. He decided to participate in the TROG 0803 (RAVES) trial, which aims to see whether treating prostate cancer patients with active surveillance is as good as immediate radiotherapy. 

Find out more about Robert's experience

Dave's story

Dave is from Pinjarra, Western Australia. After a diagnosis of throat cancer last year, Dave joined the TROG 12.03 (EAT) trial, which evaluates the effectiveness of a dietitian-delivered health behaviour intervention to reduce malnutrition in head and neck cancer patients undergoing radiotherapy.

Read Dave's story

 

Tanya's story

Tanya is from Newcastle, NSW. A shock breast cancer diagnosis led the mother-of-four to join the TROG 0806 (STARS) trial. This study compared the effectiveness of treatment with the drug anastrozole before and during radiotherapy compared with anastrozole therapy delayed until after radiotherapy, in the hope that her daughters will not have to experience the same fate. 

Read her story

Viv's story

Viv is from Adelaide, SA. When he was diagnosed with secondary lung cancer last year, the grandfather was determined not to let it derail his plans for the future. Viv decided to join the TROG 1301 (SAFRON II) trial, to receive a new form of cancer treatment called Stereotactic Ablative Body Radiotherapy (SABR), which is targeted to tumours that have limited spread from the primary to the lung.

Here is Viv's story.

Bev's story

Bev is from the Hunter Valley, NSW. A diagnosis of non-hodgkin lymphoma put her positive outlook on life to the test, But the chance to join the TROG 99.03 clinical trial gave Bev the opportunity to be part of the "bigger picture".

Learn more about Bev's experience

 

 

 

 

TROG has launched over 90 clinical trials since 1989.